
Study finds cancer survivors were 42% more likely to report walking at the slowest pace and had a 24% greater risk of mobility disability compared to individuals who never had cancer.

Study finds cancer survivors were 42% more likely to report walking at the slowest pace and had a 24% greater risk of mobility disability compared to individuals who never had cancer.

The change in guidelines address how to assess damage to the kidneys caused by fluid loss associated with severe C. diff infection.

A recent survey showed that there is a significant preference among Americans to receive COVID-19 vaccines from a trusted health care provider, such as a pharmacist or physician.

The Covid-19 pandemic has elevated telehealth as a viable alternative to face-to-face interactions under certain circumstances, the list of which is expanding as technology expands and clinicians become more accustomed to and adept in its use.

Dwight Kloth, PharmD, FCCP, BCOP, director of pharmacy at Fox Chase Cancer Center, discusses the role of the oncology pharmacist in the cancer care continuum, and how this role has been impacted by the COVID-19 pandemic.

Chad Landmon, JD, chair of intellectual property and FDA practice groups at Axinn, Veltrop & Harkrider, discusses how the COVID-19 pandemic has impacted the FDA’s approval process.

The potential for some people to skip the second COVID-19 vaccine dose may make more doses available to others.

Cecilia Lau, RPh, BCOP, APh, and Daneng Li, MD, discuss the management of stomatitis caused by everolimus when used for NETs.

Cecilia Lau, RPh, BCOP, APh, reviews the efficacy and safety data for everolimus in the treatment of NETs.

Megan May, PharmD, BCOP, and Daneng Li, MD, discuss the availability of home-injection programs for patients with NETs, especially during the coronavirus pandemic.

Experts in the management of NETs review the various delivery systems and preparations available for short- and long-acting somatostatin analogues.

Megan May, PharmD, BCOP, and Cecilia Lau, RPh, BCOP, APh, discuss the pharmacists’ role in choosing the treatment plan for patients with NETs.

The panel of experts discuss how they choose 1 somatostatin analogue over another and the factors to consider in the management of NETs.

Cecilia Lau, RPh, BCOP, APh, and Daneng Li, MD, review the differences among the somatostatin analogues, particularly the differences in PK data.

The panel of experts in the management of NETs review the indications and safety data of the somatostatin analogues.

Megan May, PharmD, BCOP, and Daneng Li, MD, review the efficacy and the pivotal trials for the somatostatin analogues in the treatment of NETs.

Experts in the management of NETs discuss how the treatment landscape has evolved.

Megan May, PharmD, BCOP, and Daneng Li, MD, discuss when patients with NETs should be considered for active surveillance vs treatment.

A panel of experts in neuroendocrine tumors provide a definition of the disease and the diagnosis methods.

The additional COVID-19 doses will provide a buffer in addition to the already procured vaccines, and will also allow experts to plan for the later part of 2021, according to a White House briefing.

New, long-term data from open-label extensions of a pair of phase 3 studies of bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets showed the sustained efficacy and safety profile of the treatment.

Research on a novel, investigational combined oral contraceptive containing drospirenone and estetrol showed that the treatment resulted in limited changes in endocrine markers.

A new study found that wearing a protective face mask has only a modest effect on the ability of healthy people to perform vigorous exercise.

When applied as a filler for soft tissue defects and voids, the regenerative tissue filler shows promise for accelerating and improving tissue restoration outcomes.

The VENTANA ALK CDx assay is a companion diagnostic to identify patients with ALK-positive non–small cell lung cancer who are eligible to receive treatment with lorlatinib.

A commonly used drug made from secondary bile acids can affect the life cycle of Clostridioides difficile.

Researchers find no clear therapeutic benefit of intravenous immunoglobulin for the prevention of postnatal relapses of multiple sclerosis.

In a recent statement, Walgreens announced that it has administered approximately 5 million COVID-19 vaccinations at long-term care facilities, in its stores, and through its vaccination clinics.

The study authors also mention that samples taken from skin biopsies confirmed their suspicion of a delayed allergic immune response that is commonly seen in drug reactions.

Osteoporosis is a skeletal condition characterized by low bone mass and deterioration of bone tissue that leads to fragility and an increased risk of fracture.